Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative APLS - Apellis Pharmaceuticals, Inc.
501 M
LAST VALUE
68.32%
2 YEAR CAGR
85.76%
5 YEAR CAGR
76.51%
10 YEAR CAGR